LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Multiple sclerosis (MS) is a disabling inflammatory demyelinating disease of the central nervous system (CNS) that primarily affects young adults. Available therapies can inhibit the inflammatory component of MS but do not suppress progressive clinical disability. An alternative approach would be to inhibit mechanisms that drive the neuropathology...
Alternative Titles
Full title
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71781361
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71781361
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/nm0602-613
